Ibrahim Moustafa | Hafenstein Lab
Understanding the structural basis of viruses is a key to learn how they work & how to eliminate them. This is true for Covid-19 as well as other viruses. In this talk, I will show how we apply a structural approach integrated with computational methods to identify compounds that could potentially develop into antiviral therapeutics. The virus example used in the presented study is Coxsackivirus B3 (CVB3), an enterovirus and a leading cause of viral myocarditis in humans.